Article
A translatable evaluation tool to study the biodistribution of clinically-available doxorubicin liposomes: PET imaging of [ <sup>89</sup> Zr]Zr-Doxil and [ <sup>89</sup> Zr]Zr-Talidox
2025-06-23
Abstract excerpt
<h4>INTRODUCTION</h4> Doxil/Caelyx is a PEGylated liposomal formulation of the chemotherapeutic doxorubicin used in the clinic for Kaposi’s sarcoma, advanced ovarian cancer, progressive multiple myeloma and metastatic breast cancer. Talidox ® , a smaller doxorubicin PEGylated liposome is undergoing clinical trials and has been proposed as an improvement on previous liposomal formulations for the treatment of adv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 19ebe446-cf54-5c79-bcf8-05d977720941
- DOI
- 10.1101/2025.06.17.660144
